Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Patient-specific dosimetry can improve treatment for neuroendocrine tumors

Patient-specific dosimetry can improve treatment for neuroendocrine tumors

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

Phase 2 clinical trial of CAR T-cell therapy starts at Atlantic Health System

TU Dresden scientists receive 4.5 million euros for fundamental research

TU Dresden scientists receive 4.5 million euros for fundamental research

Metabolite profiling during diagnosis helps identify poor treatment outcomes in ALL

Metabolite profiling during diagnosis helps identify poor treatment outcomes in ALL

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

ConvertibleCAR immunotherapy can be used to attack HIV latent reservoir

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Novel agent reduces buildup of toxic proteins in Parkinson's and Alzheimer's animal models

Discovery reveals why newer PD-1 targeted therapies sometimes fail

Discovery reveals why newer PD-1 targeted therapies sometimes fail

New collaboration aims to develop gene-based cures for sickle cell disease and HIV

New collaboration aims to develop gene-based cures for sickle cell disease and HIV

University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy

University Of Minnesota opens clinical trial of first-of-its-kind NK cell cancer immunotherapy

Reduced exercise capacity linked to neurocognitive problems in survivors of childhood ALL

Reduced exercise capacity linked to neurocognitive problems in survivors of childhood ALL

St. Jude Children's Research Hospital and IAEA team up to combat childhood cancers

St. Jude Children's Research Hospital and IAEA team up to combat childhood cancers

Adding plant-based compound to gene therapy could improve treatment outcomes

Adding plant-based compound to gene therapy could improve treatment outcomes

Vaping helps 50,000 cigarette smokers quit in England each year

Vaping helps 50,000 cigarette smokers quit in England each year

Scientists harness the power of immune system to test novel cancer treatment

Scientists harness the power of immune system to test novel cancer treatment

UTEP awarded $19.2 million NIH grant to study cancer affecting Mexican-American population

UTEP awarded $19.2 million NIH grant to study cancer affecting Mexican-American population

UCLA researchers discover new way to eliminate leukemia stem cells

UCLA researchers discover new way to eliminate leukemia stem cells

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

Combination of two drugs disrupts cancer cells' ability to survive DNA damage, study finds

Survey quantifies cancer patients' interest in pathology services

Survey quantifies cancer patients' interest in pathology services

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

Novel cancer-driving mutation discovered in vast non-coding regions of the cancer genome

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

Study may lead the way to decrease DLBCL relapse, development of second primary cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.